Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Biovica receives patent approval in Japan

Biovica International AB (publ) have received a new patent in Japan. The patent refers to Biovica's method of measuring thymidine kinase activity on a real-time PCR platform. The new patent is valid until 13th of May 2031. With this patent, Biovica has received patent protection for the PCR-based product on all 16 markets the company has applied for patent protection.”It is important for Biovica to protect our unique technology. Hence, it is positive news that we get improved patent protection on one of the more important markets. Patent protection is important in order to be able to bring

Talkpool issues up to SEK 24 million of senior secured notes

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SOUTH AFRICA OR NEW ZEALAND OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. Talkpool AG (”Talkpool” or ”the Company”) issues two-plus-one year senior secured notes amounting to maximum SEK 24 million. The bond is not dilutive to existing shareholders.The senior secured notes, which was directed to the Swedish retail market, will bear a fixed coupon of 10 percent and mature in August 2020. At the time of maturity, the

FrontOffice signs investment credit facility for fintech investment of SEK 20 million

FrontOffice Nordic AB (publ) (”FrontOffice”) has signed an investment credit facility of SEK 20 million, reserved to develop both existing holdings and continued investments within fintech. The credit has unilateral conversion rights for FrontOffice.The investment credit is provided by FTCS Intressenter AB and provides FrontOffice with an unsecured credit of up to 20 MSEK over a three-year period to an annual interest rate of 8 % on long-term credit. The investment credit also provides FrontOffice with a one-sided right to convert, on one or more occasions, the outstanding amount of loan

The Swedish FSA approves the merger between Nordea Bank AB (publ) and Nordea Bank Abp

The Swedish Financial Supervisory Authority (SFSA) has authorised Nordea to execute the merger plan regarding the merger of Nordea Bank AB (publ) into Nordea Bank Abp. This is part of the preparation for executing the merger and re-domiciliation to Finland, a member state of the European banking union. Nordea welcomes the SFSA’s authorisation to execute the merger plan. It forms a significant step for Nordea’s move to the European Banking Union following the banking licence granted by the European Central Bank on 26 June 2018. The re-domiciliation is planned to take effect on 1

Fortum Charge & Drive opens the first high-power charging station for electric vehicles in Sweden

Sweden’s first high-power charging (HPC) station was opened today by Fortum Charge & Drive in partnership with McDonald’s. The station is located at McDonald’s in Kristinehamn, some 270 kilometers west of Stockholm and midway between Oslo and Stockholm.At Kristinehamn’s HPC station next generation EVs can charge about 250 km range in only 10 minutes time. This is 7 times faster than on the quick chargers that are on the market today. The new HPC charging station in Kristinehamn is part of the first High-Power Charging (HPC) corridor that Fortum Charge & Drive is building between Oslo,

Dignitana CEO William Cronin to Speak at Aktiespararna Event in Stockholm

Dignitana AB  announced today that Chief Executive Officer William Cronin will speak at Aktiespararna’s event Aktiedagen Stockholm  on 11 September 2018. Mr. Cronin’s 20-minute presentation will be webcast live starting at 11:20 am CEST and published the following day. Event attendees will have the opportunity to ask Mr. Cronin questions following his presentation. The event is hosted by Aktiespararna, an independent organization working in the interest of private individuals who invest in stocks,

Kleresca® releases unique biophotonic rosacea treatment

Ballerup, Denmark, August 2018. Kleresca®, a medical technology company focused on the development and commercialisation of a unique biophotonic technology in dermatology, today announced the release of a new treatment for rosacea.A new biophotonic treatment for rosacea is now available to patients through aesthetic clinics across 10 markets including Denmark, UK, France, Spain, Italy, Germany, Belgium, Norway, Australia and Switzerland.   The treatment is based on Kleresca®’s unique and patented biophotonic technology which uses fluorescent light energy to stimulate the skin’s own

NetEnt launches Berryburst times two as it debuts MAX product line

NetEnt has launched Berryburst and Berryburst MAX – the first double release from its groundbreaking, mixed volatility product line.Berryburst is a frenzy of floating and fluctuating fruity fragments in a 5-reel, 3-row video slot. It features the repeatedly successful Cluster Pays™ mechanic allowing players to see big wins together with the proven top performing expanding, stacked wild re-spins mechanic, but now across all 5 reels. Berryburst MAX broadens the new game’s appeal by offering a much higher win potential using the same NetEnt game mechanics as the regular version.

Invitation to presentation of Immunovia´s interim report January-June 2018 and comments to the previously published autoimmunity study results

Lund (Sweden) - Immunovia will publish the company’s interim report for the period January-June 2018 on Friday, August 24, at 08:30 a.m. CET.Immunovia invites to a teleconference (in English) for investors, analysts and media on August 24, at 4:00 – 5:00 p.m. CET. Mats Grahn, CEO will present Immunovia and comment on the interim report, as well as comment on the press release of August 22 regarding autoimmunity study results, followed by a Q&A-session. Please call in a few minutes in advance. To attend, please dial-in at one of the numbers below from: Telephone details:SE:

Magnolia Bostad appoints Thomas Persson

Thomas Persson has been recruited to Magnolia Bostad as Regional Manager Öst and Senior Account Manager.Since it started, Magnolia Bostad has expanded strongly and today has over 6,700 units sold in production. The company is an urban developer with a further 17,700 residencies in its project portfolio consisting of rental apartments, tenant-owned apartments, residential care housing and hotels.  ”Thomas is one of the industry's most talented people and will be a major asset in our continued development,” says Fredrik Lidjan, CEO of Magnolia Bostad. Thomas Persson was previously at

Interim Report January - June 2018 Rabbalshede Kraft AB (publ)

Service Operations signed a new service agreement with Kalix Wind AB during the first half of the year. Rab­balshede Kraft manages a total of 186 turbines, of which 101 are own or co-owned · In May, Business Development acquired three operational wind turbines located in Falkenberg, Hjo and Skara · Production for the company’s own farms totaled 301,850 MWh, of which 212,802 were own and 89,048 co-owned; production was negatively impacted by poor wind condi­tions during the first quarter but rebounded, primarily in June. During the period, the company had a high level of availability, nearly

Hufvudstaden welcomes HUGO BOSS to Gothenburg

HUGO BOSS is due to open its first BOSS store in the Fredstan area of Gothenburg at the end of 2018. Located in the Hufvudstaden property at Fredsgatan 2, the store will have approximately 350 square metres of floor space on two levels, with both womenswear and menswear. The establishment of the international brand BOSS is entirely in line with the Hufvudstaden strategy of developing and reinforcing the Fredstan area.“Hufvudstaden’s aim is to offer successful retail and office tenants prime business locations in central Stockholm and central Gothenburg. We are therefore extremely pleased

STRAX: INTERIM REPORT NO 2 FOR THE FINANCIAL YEAR 2018

STRAX is taking immediate action to adjust to a rapidly changing business environment, with significant cost reductions and investments ine-commerce as well as digitalization tools to future proof the business, whilst continuing to pursue the house of brands strategy.· The Group’s sales for the period January 1 – June 30, 2018, amounted to MEUR 45.8 (43.5), gross margin increased to 32.5 (27.9) percent. · The Group’s result for the period January 1 – June 30, 2018, amounted to MEUR 0.2 (2.2) corresponding to EUR 0.02 (0.02) per share. Equity as at June 30, 2018 amounted to MEUR 20.9 (

VTT’s robot car, Martti, now “speaks 5G” and takes another step towards full automation

New 5G solutions catapult Finland to the 5G eraVTT Technical Research Centre of Finland and Nokia have joined forces to hook the VTT’s robot car, Martti, up to a 5G network, which allows the car to detect objects with improved range and share its observations with other vehicles. This also takes Martti a step closer to highly automated driving. The safety of road users also improves as new solutions and services based on 5G technology become more widely available.VTT is currently coordinating a project called 5G-Safe, which is aimed at piloting new solutions and finalising them on the

Lipidor gets go-ahead for Phase III Clinical Study of new Calcipotriol Spray treatment for psoriasis

India’s CDSCO (Central Drugs Standard Control Organization) has approved Phase III Trials of a new topical anti-psoriatic spray developed by Swedish company Lipidor. The new spray is expected to overcome patient non-compliance, a major problem for traditional psoriasis creams and ointments.   It is exceptionally fast-drying and easy to apply.Calcipotriol Spray consists of the generic Vitamin D analogue, Calcipotriol, formulated in Lipidor´s patented lipid-based drug delivery technology, AKVANO®. Lipidor has developed the clinical trial material (CTM) in cooperation with Swiss API supplier

SUMMARY OF INTERIM REPORT JANUARY - JUNE 2018

Targets in the mine construction are according to schedule and budget The processing plant in August 2018 SECOND QUARTER 2018  · Net profit was -7.9 MSEK (-2.4) and earnings per share were -0.06 SEK (-0.04). · The Group sales was 31 KSEK (60). · Investments were 50.4 MSEK (6.5). · Arto Suokas was appointed CEO of the subsidiary Sotkamo Silver Oy, Arttu Ohtonen was appointed executive vice president of Sotkamo Silver AB. · Topping-out ceremony was on June 28th and the constructions of the Silver Mine project commenced according to the planned production

NextCell's largest shareholder Diamyd Medical exercise all of its warrants

Stem cell company NextCell Pharma AB ("NXTCL") announces today, that its largest shareholder, Diamyd Medical AB, will exercise all its 296 800 series TO1 warrants. Diamyd will exercise the warrants during the subscription period which runs during the period 23rd August – 13th September 2018. This represents an investment total of SEK 1 484 000, corresponding to approximately 10 % of the outstanding warrants.The diabetes Company Diamyd Medical is one of the main owners of NextCell Pharma, with a shareholding of approximately 14 %. In addition to its current shares, Diamyd Medical also has

Polygiene AB (publ.) Interim Report 1 Januari–30 June 2018

Strong growth in April and May and earnings improveQ2 in brief · In the second quarter, net sales were to MSEK 16.6 (14.6), which corresponds to a 14% increase compared to the same period last year. · The operating profit/loss (EBIT) for the period improved compared to the same period last year and amounted to MSEK -1.9 (-3.7). · Cash flow for the second quarter was MSEK -4.2 (-3.5). · The gross margin amounted to 63% (65%). ·  Strong growth during the first two months of the quarter temporarily slackened off in June. The third quarter initially shows signs of strong growth.

ChromoGenics receives order of approximately 220 sqm ConverLight® dynamic glass to Åke Sundvall

ChromoGenics AB (publ) has signed an agreement with Åke Sundvall Byggnads AB to deliver ConverLight® to the project Knäckepilen in Uppsala.ChromoGenics has signed an agreement to deliver approximately 220 sqm of dynamic glass to the project Knäckepilen at Gränbystaden in Uppsala, where Åke Sundvall builds condominiums. ConverLight® will be delivered during the second half of 2018, and time for moving in to the apartments is scheduled for the first quarter of 2019. "People need daylight. In the project Knäckepilen we have focused on innovative architecture and integrated large glass

Interim report second quarter 2018

During the second quarter 2018 sales for PowerCell Sweden AB (publ) more than doubled from MSEK 6.0 to MSEK 13.5 compared to the same period last year, driven by increased customer activities and orders. Operating income for the period was MSEK -19.3 (-18.0).“The awareness about the acute climate situation is increasing and driving interest in us and our products”, Per Wassén, CEO of PowerCell said. “At the same time we continue our structured work to step by step build the company to be better able to both support and to benefit from the necessary transformation.”The English version is

Interim report April - June 2018

Second quarter · Net sales amounted to MSEK 6.1 (28.5)  · EBITDA amounted to MSEK -1.7 (2.3)  · EBIT amounted to MSEK -3.9 (-2.8)  · EBT amounted to MSEK -4.0 (-5.5)  · Earnings per share before dilutions amounted to SEK -0.08 (-0.15)  · Listed on Oslo Stock Exchange, Merkur Market  First half year · Net sales amounted to MSEK 13.6 (57.6)  · EBITDA amounted to MSEK -5.9 (4.3)  · EBIT amounted to MSEK -10.3 (-5.7)  · EBT amounted to MSEK -14.4 (-11.3)  · Earnings per share before dilutions amounted to SEK -0.31 (-0.33)  Significant events after the

There are no items matching the current filter
There are no more items matching the current filter
Back to top